Showing results (81-90 of 385) with videos related to
Sort By:
Pageof 39
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|February 2, 1999
Heart health promotion: predisposition, capacity and implementation in Ontario Public Health Units, 1994-96S M Taylor, S Elliott, B RileyBlood|May 1, 1996
Efficient retroviral transduction of human bone marrow progenitor and long-term culture-initiating cells: partial reconstitution of cells from patients with X-linked chronic granulomatous disease by gp91-phox expressionC D Porter, M H Parkar, M K Collins, et al.Blood|October 1, 1993
X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phoxC D Porter, M H Parkar, R J Levinsky, et al.Annales De Recherches Veterinaires. Annals of Veterinary Research|January 1, 1988
Efficacy of a levamisole bolus in Ostertagia and Cooperia infectionsS M Taylor, T Mallon, B CarrolJournal of Comparative Pathology|July 1, 1983
The effect of route of administration of a Babesia divergens inactivated vaccine on protection against homologous challengeS M Taylor, J Kenny, T MallonJournal of Immunological Methods|November 5, 1992
Superoxide production by normal and chronic granulomatous disease (CGD) patient-derived EBV-transformed B cell lines measured by chemiluminescence-based assaysC D Porter, M H Parkar, M K Collins, et al.Science (New York, N.Y.)|October 3, 1975
Enhancement of mouse cytomegalovirus infection during host-versus-graft reactionB C Wu, J N Dowling, J A Armstrong, et al.Clinical and Experimental Immunology|June 1, 1987
Western blot profiles, lymph node ultrastructure and viral expression in HIV-infected patients: a correlative studyP U Cameron, R L Dawkins, J A Armstrong, et al.American Journal of Ophthalmology|February 1, 1983
The role of herpesvirus type 1 thymidine kinase in experimental ocular infectionsY J Gordon, J A Armstrong, S I Brown, et al.The Journal of Infectious Diseases|April 1, 1976
Cytomegalovirus infection in patients receiving immunosuppressive therapy for rheumatologic disordersJ N Dowling, A R Saslow, J A Armstrong, et al.Pageof 39